Gloria Feldt (R), President of the Planned Parenthood Federation of America and Dr. Richard U. Hausknecht OB/GYN, Medical Director of Danco Labratories smile as they listen to a speaker at a press conference called by Danco Labratories in New York, September 28, 2000. The press conference followed the Federal Drug Administration's (FDA) approval of the drug Mifeprex (Mifepristone), the early option abortion pill for women. Danco Labratories, under the direction of Dr. Hausknecht, has been granted exclusive license from the Population Council to manufacture, market and distribute Mifeprex in the United States.